Clinical Trials Directory

Trials / Completed

CompletedNCT04028453

Follow up of Increased Nuchal Translucency :Study of 2010 to 2018 of Limoges Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
392 (actual)
Sponsor
University Hospital, Limoges · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers

Summary

The ultrasound of the first trimester allows to determinate the pregnancy beginning, the type of pregnancy and also to detect increased nuchal translucency (NT). Fetuses with common chromosomal abnormalities (trisomies 21, 18 and 13 and monosomy X) and structural abnormalities (particularly cardiac defects) and single-gene disorders frequently show increased NT. The purpose of this study is to evaluate in the population of Limousin, the type and frequency of these abnormalities.

Detailed description

Increased NT superior than 95th percentile (Nicolaides curves) during the ultrasound of the first trimester, are associated to common chromosomal abnormalities. It's therefore necessary to make amniocentesis and to analyze karyotyping and Genomic microarrays, also known as chromosomal microarrays (CMA). In euploid foetus, increased NT is also associated with structural defects or genetic syndromes. Additionally, the overall long-term growth of euploid children with increased NT is not much known. The majority (98%) of euploid children with a normal second trimester ultrasound is apparently healthy in the short run. The investigator's objective is to evaluate in a retrospective way, different events (structural defects, chromosomal or genetic abnormalities) during these pregnancies. In a prospective way, the neurodevelopmental disorders in euploid children will be investigated.

Conditions

Interventions

TypeNameDescription
OTHERSurveyThere will be a first part with a retrospective study in order to collect pregnancy data to answer to the primary endpoint. Then, there will be a prospective part where mothers and their children will have to answer an evaluation survey.

Timeline

Start date
2019-10-25
Primary completion
2020-10-25
Completion
2020-10-25
First posted
2019-07-22
Last updated
2021-09-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04028453. Inclusion in this directory is not an endorsement.